Unknown

Dataset Information

0

Inhibition of H1 and H5 Influenza A Virus Entry by Diverse Macrocyclic Peptides Targeting the Hemagglutinin Stem Region.


ABSTRACT: Influenza A viruses pose a serious pandemic risk, while generation of efficient vaccines against seasonal variants remains challenging. There is thus a pressing need for new treatment options. We report here a set of macrocyclic peptides that inhibit influenza A virus infection at low nanomolar concentrations by binding to hemagglutinin, selected using ultrahigh-throughput screening of a diverse peptide library. The peptides are active against both H1 and H5 variants, with no detectable cytotoxicity. Despite the high sequence diversity across hits, all tested peptides were found to bind to the same region in the hemagglutinin stem by HDX-MS epitope mapping. A mutation in this region identified in an escape variant confirmed the binding site. This stands in contrast to the immunodominance of the head region for antibody binding and suggests that macrocyclic peptides from in vitro display may be well suited for finding new druggable sites not revealed by antibodies. Functional analysis indicates that these peptides stabilize the prefusion conformation of the protein and thereby prevent virus-cell fusion. High-throughput screening of macrocyclic peptides is thus shown here to be a powerful method for the discovery of novel broadly acting viral fusion inhibitors with therapeutic potential.

SUBMITTER: Pascha MN 

PROVIDER: S-EPMC9486808 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of H1 and H5 Influenza A Virus Entry by Diverse Macrocyclic Peptides Targeting the Hemagglutinin Stem Region.

Pascha Mirte N MN   Thijssen Vito V   Egido Julia E JE   Linthorst Mirte W MW   van Lanen Jipke H JH   van Dongen David A A DAA   Hopstaken Antonius J P AJP   van Kuppeveld Frank J M FJM   Snijder Joost J   de Haan Cornelis A M CAM   Jongkees Seino A K SAK  

ACS chemical biology 20220804 9


Influenza A viruses pose a serious pandemic risk, while generation of efficient vaccines against seasonal variants remains challenging. There is thus a pressing need for new treatment options. We report here a set of macrocyclic peptides that inhibit influenza A virus infection at low nanomolar concentrations by binding to hemagglutinin, selected using ultrahigh-throughput screening of a diverse peptide library. The peptides are active against both H1 and H5 variants, with no detectable cytotoxi  ...[more]

Similar Datasets

| S-EPMC4139235 | biostudies-literature
| S-EPMC4607479 | biostudies-literature
| S-EPMC4406500 | biostudies-literature
| S-EPMC7323124 | biostudies-literature
| S-EPMC7563823 | biostudies-literature
| S-EPMC3911584 | biostudies-literature
| S-EPMC8900595 | biostudies-literature
| S-EPMC10147081 | biostudies-literature
| S-EPMC11584116 | biostudies-literature
| S-EPMC4810667 | biostudies-literature